Clinical Operations and Study Execution

Our Clinical Operations team delivers end-to-end execution for Bioavailability and Bioequivalence (BA/BE) studies, supporting global regulatory submissions (US FDA, EMA, PPB, MHRA, CDSCO etc). Backed by a purpose-built Clinical Pharmacology Unit (CPU) with dedicated confinement capacity, 24/7 medical oversight, and an extensive biometric-verified volunteer registry, we guarantee rapid study startup, zero cross-participation, and total compliance with ICH-GCP guidelines

From protocol design and expedited Ethics Committee (IEC/IRB) approvals to standardized fed/fasting meal administration and direct-observation dosing, every study phase is tightly controlled. Our operational workflows prioritize precision pharmacokinetic (PK) blood collection, using tracked serial sampling, refrigerated centrifugation, and deep-freeze cryostorage, to protect sample integrity before bioanalytical handover

By combining stringent quality control, global regulatory compliant data management, and continuous safety monitoring, we minimize pre analytical variability and accelerate study timelines. Partner with us for dependable, audit ready clinical study execution that brings generic and modified-release therapeutics to market faster